ACR Convergence 2023

November 10-15, 2023. San Diego, CA.

View by Number View by Title View Sessions

Abstract Number: 2064

Perceptions of Rheumatology Fellows on Mentorship Quality After Implementation of a Formalized Mentorship Program
Abstract Number: 2065

Exploring the Power of Ultrasound in Rheumatology: Insights from Young Rheumatologists in Mexico
Abstract Number: 2066

Ultrasound Guided Synovial Biopsy Course: Achievement of Learner Self Efficacy
Abstract Number: 2067

A New Tool Assessing Trainees’ Interventional Musculoskeletal Ultrasound Skills
Abstract Number: 2068

Integration of Basic Science into Virtual Patient Cases to Enhance Clinical Reasoning Skills
Abstract Number: 2069

Navigating the Residency-to-Fellowship Transition in Rheumatology
Abstract Number: 2070

Augmenting Medical Education: An Evaluation of GPT-4 and ChatGPT in Answering Rheumatology Questions from the Spanish Medical Licensing Examination
Abstract Number: 2071

A Consensus Based Shoulder Examination for Rheumatology Training
Abstract Number: 2072

Utility of a Novel Pediatric Rheumatology Interactive Teleconference Series: Rheum2Play
Abstract Number: 2073

Outcomes of the First Year of a Rheumatology Curriculum at Two Internal Medicine Residency Programs
Abstract Number: 2074

Creation and Dissemination of a Near-Peer Rheumatology Fellowship Bootcamp
Abstract Number: 2075

The Impact of Rheumatology Fellow Initiated Curriculum Design on Resident Education
Abstract Number: 2076

Piloting a Rheumatology and Sports Medicine Case-Based Collaborative Learning Curriculum for Medical Students
Abstract Number: 2077

A Curriculum of Online Education Significantly Improved Rheumatologists’ Knowledge, Competence and Confidence in Managing Patients with Spondyloarthritis
Abstract Number: 2078

Interim Evaluation of a 6 Year Remote Online Adaptive Learning Platform Module for Rheumatology Fellows: Applied Rheumatology on the Go

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].